Streamex Corp. — Form 8-K Summary
Business context and reporting period
Streamex Corp. (Nasdaq: STEX) filed this current report regarding a Nasdaq listing deficiency. The report is dated October 7, 2026, and was signed October 9, 2026. It does not report results for a financial reporting period.
Financial metrics
The filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures.
Material development
Nasdaq notified the Company on October 7, 2026 that its closing bid price had been below the $1.00 minimum for 30 consecutive business days, from August 25 through October 6, 2026. The shares remain listed and trading on the Nasdaq Capital Market under STEX while the Company seeks to address the deficiency.
Compliance timeline, outlook, and risks
- The Company has until April 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days; Nasdaq may require a longer period.
- The Company says it will monitor the share price and consider available options, which may include a reverse stock split. Any reverse split used to cure the issue must be completed at least 10 business days before the deadline.
- If the bid price is $0.10 or less for 10 consecutive trading days during the compliance period, Nasdaq will issue a Staff Delisting Determination.
- An additional 180-day compliance period may be available if the Company meets other applicable requirements and gives Nasdaq written notice of its intent to cure. Otherwise, failure to regain compliance could result in delisting, subject to appeal rights.
- The Company cautions that it cannot assure compliance will be regained. It identifies market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets among the risks to its forward-looking statements.
Important facts for investors to verify
- Whether STEX regains the $1.00 minimum bid price for the required period by April 5, 2027.
- Whether the Company pursues a reverse stock split or qualifies for an additional compliance period.
- Any subsequent Nasdaq notice, delisting determination, or appeal, and the Company’s continued compliance with other listing requirements.